LIONVILLE, Pa., Mar 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has declared a dividend of $.19 per share for the second quarter of 2002 payable May 1, 2002 to shareholders of record April 17, 2002.
LIONVILLE, Pa., Mar 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has declared a dividend of $.19 per share for the second quarter of 2002 payable May 1, 2002 to shareholders of record April 17, 2002.
LIONVILLE, Pa., Feb 14, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Net Income From Continuing Operations Up 76% on 11% Increase in Revenue - - Comparable 2002 Earnings Expected to Grow by Between 13% and 19% - West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the
LIONVILLE, Pa., Feb 14, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Net Income From Continuing Operations Up 76% on 11% Increase in Revenue - - Comparable 2002 Earnings Expected to Grow by Between 13% and 19% - West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the
LIONVILLE, Pa., Feb 8, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and year-end financial results before the open of the market on Thursday, February 14, 2002. William G.
LIONVILLE, Pa., Feb 8, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and year-end financial results before the open of the market on Thursday, February 14, 2002. William G.
LIONVILLE, Pa., Dec 6, 2001 /PRNewswire via COMTEX/ -- Sharpens Focus on Growth Markets for Pharmaceutical Technologies West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will consolidate operations into two divisions, which will be named the Pharmaceutical Systems and Drug
LIONVILLE, Pa., Dec 6, 2001 /PRNewswire via COMTEX/ -- Sharpens Focus on Growth Markets for Pharmaceutical Technologies West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will consolidate operations into two divisions, which will be named the Pharmaceutical Systems and Drug
LIONVILLE, Pa., Dec 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that Michael Myers, Ph.D., has joined West as President of the Drug Delivery Systems Division. Dr. Myers, age 40, most recently held the position of Executive Vice President,
LIONVILLE, Pa., Dec 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that Michael Myers, Ph.D., has joined West as President of the Drug Delivery Systems Division. Dr. Myers, age 40, most recently held the position of Executive Vice President,
LIONVILLE, Pa., Dec 4, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.19 per share for the first quarter of 2002 payable February 6, 2002 to shareholders of record January 23, 2002.
LIONVILLE, Pa., Dec 4, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.19 per share for the first quarter of 2002 payable February 6, 2002 to shareholders of record January 23, 2002.
LIONVILLE, Pa., Dec 3, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and Novartis Animal Health Inc. have extended their 1999 development program that involves the delivery of oral vaccines using West's proprietary technologies.
LIONVILLE, Pa., Dec 3, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and Novartis Animal Health Inc. have extended their 1999 development program that involves the delivery of oral vaccines using West's proprietary technologies.
LIONVILLE, Pa., Nov 30, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today completed the previously announced sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc., an affiliate of DPT
LIONVILLE, Pa., Nov 30, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today completed the previously announced sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc., an affiliate of DPT
LIONVILLE, Pa., Nov 15, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it entered into a definitive agreement for the sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc.,
LIONVILLE, Pa., Nov 15, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it entered into a definitive agreement for the sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc.,
DENVER, Oct. 22 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) introduced Clip'n'Ject(TM), a proprietary and novel system for improving the point-of-care reconstitution and delivery of lyophilized or dry-powder drugs, at the American Association of Pharmaceutical Scientists (AAPS)
DENVER, Oct. 22 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) introduced Clip'n'Ject(TM), a proprietary and novel system for improving the point-of-care reconstitution and delivery of lyophilized or dry-powder drugs, at the American Association of Pharmaceutical Scientists (AAPS)
LIONVILLE, Pa., Oct. 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced financial results for the third quarter and nine months ended September 30, 2001. Net income for the third quarter was $5.9 million, or $0.41 per diluted share, compared to $4.6 million, or $0.32
LIONVILLE, Pa., Oct. 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced financial results for the third quarter and nine months ended September 30, 2001. Net income for the third quarter was $5.9 million, or $0.41 per diluted share, compared to $4.6 million, or $0.32
LIONVILLE, Pa., Oct. 15 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter financial results before the open of the market on Wednesday, October 17, 2001. William G. Little, Chairman and Chief Executive Officer and Dr. Donald E.
LIONVILLE, Pa., Oct. 15 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter financial results before the open of the market on Wednesday, October 17, 2001. William G. Little, Chairman and Chief Executive Officer and Dr. Donald E.
LIONVILLE, Pa., Oct 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. announced that its Board of Directors has declared a dividend of $.19 per share for the fourth quarter of 2001 payable November 7, 2001 to shareholders of record October 24, 2001.
LIONVILLE, Pa., Oct 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. announced that its Board of Directors has declared a dividend of $.19 per share for the fourth quarter of 2001 payable November 7, 2001 to shareholders of record October 24, 2001.
LIONVILLE, Pa., Sep 24, 2001 /PRNewswire/ -- Proprietary Oral Delivery System, TARGIT-Budesonide, to Potentially Improve Effectiveness and Reduce Side-Effects for Treatment of Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn's Disease West Pharmaceutical Services, Inc.
LIONVILLE, Pa., Sep 24, 2001 /PRNewswire/ -- Proprietary Oral Delivery System, TARGIT-Budesonide, to Potentially Improve Effectiveness and Reduce Side-Effects for Treatment of Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn's Disease West Pharmaceutical Services, Inc.
LIONVILLE, Pa., Sep 13, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that J. Roffe Wike, II died at home on September 10th, 2001 following a brief illness. Mr. Wike was a member of the Company's Board of Directors for almost 40 years and the son of one of the
LIONVILLE, Pa., Sep 13, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that J. Roffe Wike, II died at home on September 10th, 2001 following a brief illness. Mr. Wike was a member of the Company's Board of Directors for almost 40 years and the son of one of the
LIONVILLE, Pa., Aug. 6 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has successfully completed conversion of its business processes and systems in the Eurozone from national currencies to the Euro. The company now has the capabilities to offer full business
LIONVILLE, Pa., Aug. 6 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has successfully completed conversion of its business processes and systems in the Eurozone from national currencies to the Euro. The company now has the capabilities to offer full business
LIONVILLE, Pa., July 24 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today clarified references to Debiotech, S.A. and Debiopharm, S.A. that were contained in recent company press releases. In a release issued July 17, 2001, West Pharmaceutical Services referred to Debiotech, S.A.
LIONVILLE, Pa., July 24 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today clarified references to Debiotech, S.A. and Debiopharm, S.A. that were contained in recent company press releases. In a release issued July 17, 2001, West Pharmaceutical Services referred to Debiotech, S.A.
LIONVILLE, Pa., Jul 19, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter and six months ended June 30, 2001. Net sales for the second quarter increased 3% to $117.2 million compared to the $113.6 million reported in the second
LIONVILLE, Pa., Jul 19, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter and six months ended June 30, 2001. Net sales for the second quarter increased 3% to $117.2 million compared to the $113.6 million reported in the second
LIONVILLE, Pa., July 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced the first significant commercial milestone in its new initiative to manufacture and market an advanced single dose delivery drug reconstitution system. Debiopharm, S.A., a Swiss-based pharmaceutical
LIONVILLE, Pa., July 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced the first significant commercial milestone in its new initiative to manufacture and market an advanced single dose delivery drug reconstitution system. Debiopharm, S.A., a Swiss-based pharmaceutical
LIONVILLE, Pa., Jul 2, 2001 /PRNewswire/ -- West Pharmaceutical Services' Patented ChiSys(TM) Nasal Delivery System to be Developed for Influvac(TM) Vaccine, Now Used by Millions of Patients in More Than 35 Countries West Pharmaceutical Services, Incorporated (NYSE: WST) today announced completion
LIONVILLE, Pa., Jul 2, 2001 /PRNewswire/ -- West Pharmaceutical Services' Patented ChiSys(TM) Nasal Delivery System to be Developed for Influvac(TM) Vaccine, Now Used by Millions of Patients in More Than 35 Countries West Pharmaceutical Services, Incorporated (NYSE: WST) today announced completion
LIONVILLE, Pa., June 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the third quarter of 2001 payable August 1, 2001 to shareholders of record July 18, 2001.
LIONVILLE, Pa., June 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the third quarter of 2001 payable August 1, 2001 to shareholders of record July 18, 2001.
LIONVILLE, Pa., May 11 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the promotion of Linda R. Altemus, 49, to the position of Vice President, Finance and Administration, effective June 30, 2001. In her new role, Ms. Altemus will oversee the Company's financial and
LIONVILLE, Pa., May 11 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the promotion of Linda R. Altemus, 49, to the position of Vice President, Finance and Administration, effective June 30, 2001. In her new role, Ms. Altemus will oversee the Company's financial and
LIONVILLE, Pa., May 1 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the conclusion of its review of strategic alternatives which it was conducting with the assistance of its financial advisor UBS Warburg LLC. The Board of Directors concluded that there is a growing
LIONVILLE, Pa., May 1 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the conclusion of its review of strategic alternatives which it was conducting with the assistance of its financial advisor UBS Warburg LLC. The Board of Directors concluded that there is a growing
LIONVILLE, Pa., April 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced improved results for the first quarter ended March 31, 2001. Net income for the first quarter was $5.4 million, or $0.38 per share, compared with net income of $5.1 million, or $0.35 per share,
LIONVILLE, Pa., April 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced improved results for the first quarter ended March 31, 2001. Net income for the first quarter was $5.4 million, or $0.38 per share, compared with net income of $5.1 million, or $0.35 per share,
LIONVILLE, Pa., March 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the second quarter of 2001 payable May 2, 2001 to shareholders of record April 18, 2001.
LIONVILLE, Pa., March 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the second quarter of 2001 payable May 2, 2001 to shareholders of record April 18, 2001.
LIONVILLE, Pa., Feb. 27 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the fourth quarter and year-ended December 31, 2000. The results are consistent with guidance provided by management on January 29, 2001.
LIONVILLE, Pa., Feb. 27 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the fourth quarter and year-ended December 31, 2000. The results are consistent with guidance provided by management on January 29, 2001.
LIONVILLE, Pa., Feb. 5 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will present at the UBS Warburg Global Healthcare Services Conference on Tuesday, February 6, 2001 at 2:00 p.m. at the New York Plaza Hotel. Dr. Donald E.
LIONVILLE, Pa., Feb. 5 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will present at the UBS Warburg Global Healthcare Services Conference on Tuesday, February 6, 2001 at 2:00 p.m. at the New York Plaza Hotel. Dr. Donald E.
LIONVILLE, Pa., Jan. 29 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today commented on expected results for the fourth quarter and year ended December 31, 2000. As disclosed previously, soft market conditions and project delays resulted in lower sales volumes in the contract
LIONVILLE, Pa., Jan. 29 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today commented on expected results for the fourth quarter and year ended December 31, 2000. As disclosed previously, soft market conditions and project delays resulted in lower sales volumes in the contract
LIONVILLE, Pa., Dec. 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the first quarter of 2001 payable February 7, 2001 to shareholders of record January 24, 2001.
LIONVILLE, Pa., Dec. 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the first quarter of 2001 payable February 7, 2001 to shareholders of record January 24, 2001.
LIONVILLE, Pa., Nov. 16 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved corporate initiatives designed to streamline operations and improve efficiencies. The Company stated that these initiatives are independent of UBS Warburg's
LIONVILLE, Pa., Nov. 16 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved corporate initiatives designed to streamline operations and improve efficiencies. The Company stated that these initiatives are independent of UBS Warburg's
LIONVILLE, Pa., Oct. 16 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported net income of $4.6 million, or $0.32 per share, compared with third quarter 1999 net income of $8.6 million, or $0.58 per share. In the Device Product Development segment, strong sales growth in
LIONVILLE, Pa., Oct. 16 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported net income of $4.6 million, or $0.32 per share, compared with third quarter 1999 net income of $8.6 million, or $0.58 per share. In the Device Product Development segment, strong sales growth in
LIONVILLE, Pa., Aug. 1 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the fourth quarter of 2000 payable November 1, 2000 to shareholders of record on October 18, 2000.
LIONVILLE, Pa., Aug. 1 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the fourth quarter of 2000 payable November 1, 2000 to shareholders of record on October 18, 2000.
LIONVILLE, Pa., July 20 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter and six months ended June 30, 2000. Net sales for the second quarter were $112.7 million compared to the $124.4 million reported in the second quarter of 1999.
LIONVILLE, Pa., July 20 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter and six months ended June 30, 2000. Net sales for the second quarter were $112.7 million compared to the $124.4 million reported in the second quarter of 1999.
LIONVILLE, Pa., June 21 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported that earnings for the second quarter ending June 30, 2000 and for the year are expected to be sharply lower than previously anticipated. The Company stated that the previously disclosed soft
LIONVILLE, Pa., June 21 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported that earnings for the second quarter ending June 30, 2000 and for the year are expected to be sharply lower than previously anticipated. The Company stated that the previously disclosed soft
LIONVILLE, Pa., June 20 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.17 per share for the third quarter of 2000 payable August 2, 2000 to shareholders of record July 19, 2000.
LIONVILLE, Pa., June 20 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.17 per share for the third quarter of 2000 payable August 2, 2000 to shareholders of record July 19, 2000.
LIONVILLE, Pa., April 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the first quarter ended March 31, 2000. Sales for the first quarter were $107.7 million compared to the $114.2 million reported in the first quarter of 1999.
LIONVILLE, Pa., April 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the first quarter ended March 31, 2000. Sales for the first quarter were $107.7 million compared to the $114.2 million reported in the first quarter of 1999.
LIONVILLE, Pa., March 27 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.17 per share for the second quarter of 2000 payable May 3, 2000 to shareholders of record April 19, 2000.
LIONVILLE, Pa., March 27 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.17 per share for the second quarter of 2000 payable May 3, 2000 to shareholders of record April 19, 2000.
LIONVILLE, Pa., March 2 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it has entered into a product development agreement with Beaufor Ipsen, S.A., a privately held French Pharmaceutical Group. The agreement involves the application of West's patented nasal
LIONVILLE, Pa., March 2 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it has entered into a product development agreement with Beaufor Ipsen, S.A., a privately held French Pharmaceutical Group. The agreement involves the application of West's patented nasal
LIONVILLE, Pa., Feb. 15 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the fourth quarter and year-ended December 31, 1999. Sales for the fourth quarter were $115.4 million, compared with $114.8 million reported in the fourth quarter of 1998.
LIONVILLE, Pa., Feb. 15 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the fourth quarter and year-ended December 31, 1999. Sales for the fourth quarter were $115.4 million, compared with $114.8 million reported in the fourth quarter of 1998.
LIONVILLE, Pa., Jan. 31 /PRNewswire/ -- West Pharmaceutical Services, Incorporated (NYSE: WST) announced today that it completed filling of an Investigational New Drug (IND) application covering a nasally administered formulation of leuprolide for the treatment of endometriosis and other selected
LIONVILLE, Pa., Jan. 31 /PRNewswire/ -- West Pharmaceutical Services, Incorporated (NYSE: WST) announced today that it completed filling of an Investigational New Drug (IND) application covering a nasally administered formulation of leuprolide for the treatment of endometriosis and other selected
